Celldex Therapeutics
CLDX
#4701
Rank
NZ$3.38 B
Marketcap
NZ$50.98
Share price
-0.51%
Change (1 day)
15.07%
Change (1 year)

Celldex Therapeutics (CLDX) - Cash on Hand

Cash on Hand as of September 2025 : NZ$1.00 Billion

According to Celldex Therapeutics's latest financial reports the company has NZ$1.00 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celldex Therapeutics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$1.28 B91.99%
2023-12-31NZ$0.66 B39.46%
2022-12-31NZ$0.48 B-19.64%
2021-12-31NZ$0.59 B121.82%
2020-12-31NZ$0.26 B181.86%
2019-12-31NZ$95.59 M-31.8%
2018-12-31NZ$0.14 B-28.6%
2017-12-31NZ$0.19 B-28.34%
2016-12-31NZ$0.27 B-35.32%
2015-12-31NZ$0.42 B65.07%
2014-12-31NZ$0.25 B-30.41%
2013-12-31NZ$0.36 B261.24%
2012-12-31NZ$0.10 B49.42%
2011-12-31NZ$68.3 M-13.75%
2010-12-31NZ$79.19 M-30.24%
2009-12-31NZ$0.11 B48.85%
2008-12-31NZ$76.26 M1089.87%
2007-12-31NZ$6.4 M-88.96%
2006-12-31NZ$58.07 M69.48%
2005-12-31NZ$34.26 M-22.97%
2004-12-31NZ$44.48 M42.79%
2003-12-31NZ$31.15 M-34.97%
2002-12-31NZ$47.9 M-53.38%
2001-12-31NZ$0.10 B-9.26%
2000-12-31NZ$0.11 B334.49%
1999-12-31NZ$26.06 M54.31%
1998-12-31NZ$16.88 M53.13%
1997-12-31NZ$11.02 M-38.16%
1996-12-31NZ$17.83 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Seagen
SGEN
NZ$2.14 B 112.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$5.98 M-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.42 B-57.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.34 B 1,519.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$25.93 B 2,469.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$7.69 B 662.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
NZ$4.85 M-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA